Company / Cash per Share
Revolution Medicines, Inc. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.06
FY2025
5-year range
$1.46 / $7.70
FY2021-FY2025
Trend
-37.4%
vs FY2024
Sector context
#101 of 205
Health Care
What the data says
At $2.06, Revolution Medicines, Inc.'s cash per share ranks #101 of 205 in the Health Care sector. Declined from $7.70 to $2.06 over the past 2 years.
Based on SEC 10-K filings.
2.06 in FY2025 with a 5-year CAGR of -16.4%.
Declined from $7.70 to $2.06 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +12.2%
- 5-Year CAGR
- -16.4%
- 10-Year CAGR
- -
Sector benchmark
#101 of 205 in Health CareTop 49% of 205This company $2.06 Sector average $67.98
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 37.4% year-over-year.
- Ranks #101 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.06 | -37.4% |
| FY2024 | $3.30 | -57.2% |
| FY2023 | $7.70 | +426.2% |
| FY2022 | $1.46 | -6.5% |
| FY2021 | $1.57 | -69.1% |
| FY2020 | $5.06 | -15.8% |
| FY2019 | $6.01 | -80.2% |
| FY2018 | $30.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026